Background: The prognosis of idiopathic pulmonary fibrosis (IPF) is the worst among all interstitial lung diseases, and is related to the disease itself. Comorbidities or complications can worsen IPF. We assessed the effect of...
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically significant, respiratory deterioration of unidentifiable cause. The objective of this international working group report on acute...
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a dismal prognosis. The average life expectancy of untreated patients with IPF is only 3 to 4 years. Decline in forced vital capacity (FVC) in patients with IPF appears to be...
Results also show that gout is more than twice as likely in alcoholic patients and more than three times as likely in obese patients.1
Abundant epidemiologic evidence supports an association between idiopathic pulmonary fibrosis (IPF) and lung cancer. Lung tumors in patients with IPF develop preferentially in the periphery immediately adjacent to fibrotic areas...
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is destroyed, which leads to decreased lung compliance...
Background: Idiopathic pulmonary fibrosis (IPF) is a disease with poor prognosis mainly affecting males.
Background: Sarcopenia can contribute to negative outcomes in patients with various lung diseases.
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by variable progression.
This guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over.